Biotech Values

[DewDiligence]

Not that all such data is needed for people to provide opinions of course, happens all the time.

Indeed, such opinionating must happen. Whether they do it explicitly or implicitly, investors in such companies as REGN and AMGN need to ascribe a value to the PCSK9 programs to know whether the stocks should be bought or sold.

Still, I won’t set up an iHub survey if there is only tepid interest in the subject at this point. When the number of survey votes is small, the tally is insufficiently illuminating to be worth the trouble.